Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB11 | O95342 | 3/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.42 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.42 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.42 |
| ▸ | DRD1 | P21728 | 2/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.42 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.42 |
| ▸ | HTR2B | P41595 | 2/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.42 |
| ▸ | HTR2A | P28223 | 1/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.42 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5918076 | 0.84 | ABCB11 (0.46) | ABCB11CYP2C19ADRA2ACYP2B6DRD1 | |
| Sulfuric Acid SCHEMBL6363639 | 0.84 | ABCB11 (0.50) | ABCB11CYP2C19ADRA2ACYP2B6DRD1 | |
| Sulfuric Acid SCHEMBL951856 | 0.84 | ABCB11 (0.50) | ABCB11CYP2C19ADRA2ACYP2B6DRD1 | |
| SCHEMBL1986102 | 0.83 | ABCB11 (0.46) | ABCB11CYP2C19ADRA2ACYP2B6DRD1 | |
| Sulfuric Acid SCHEMBL6363645 | 0.82 | ABCB11 (0.48) | ABCB11CYP2C19ADRA2ACYP2B6DRD1 | |
| Sulfuric Acid SCHEMBL6375982 | 0.82 | ABCB11 (0.48) | ABCB11CYP2C19ADRA2ACYP2B6DRD1 | |
| SCHEMBL954553 | 0.81 | DRD1 (0.47) | ABCB11CYP2C19ADRA2ACYP2B6DRD1 | |
| SCHEMBL1269320 | 0.81 | DRD1 (0.47) | ABCB11CYP2C19ADRA2ACYP2B6DRD1 | |
| SCHEMBL3628834 | 0.81 | ABCB11 (0.44) | ABCB11CYP2C19ADRA2ACYP2B6DRD1 | |
| Bromide SCHEMBL2087060 | 0.80 | DRD1 (0.46) | ABCB11CYP2C19ADRA2ACYP2B6DRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111440139-A | Preparation method of clopidogrel sulfonate impurity | 廊坊市泽康医药科技有限公司 | 2020-07-24 | — | — | CN | claimed |
| CN-109867684-B | Preparation method of II-type clopidogrel hydrogen sulfate | 武汉武药制药有限公司 | 2022-06-17 | — | — | CN | disclosed |
| CN-111440139-A | Preparation method of clopidogrel sulfonate impurity | 廊坊市泽康医药科技有限公司 | 2020-07-24 | — | — | CN | disclosed |
| CN-111440139-A | Preparation method of clopidogrel sulfonate impurity | 廊坊市泽康医药科技有限公司 | 2020-07-24 | — | — | CN | disclosed |
| CN-109867684-A | A kind of preparation method of II type bisulfate clopidogrel | 武汉武药制药有限公司 | 2019-06-11 | — | — | CN | disclosed |
| CN-101253179-B | Novel resinate complex of S-clopidogrel and production method thereof | CHONG KUN DANG PHARM CORP | 2010-12-29 | — | — | CN | disclosed |
| US-20080226579-A1 | Novel Resinate Complex of S-Clopidogrel and Production Method Thereof | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2008-09-18 | — | — | US | disclosed |
| CN-101253179-A | Novel resinate complex of S-clopidogrel and production method thereof | CHONG KUN DANG PHARM CORP (KR) | 2008-08-27 | — | — | CN | disclosed |
| EP-1926736-A1 | NOVEL RESINATE COMPLEX OF S-CLOPIDOGREL AND PRODUCTION METHOD THEREOF | Chong Kun Dang Pharmaceutical Corp. (KR) | 2008-06-04 | — | — | EP | disclosed |
| WO-2007035028-A1 | NOVEL RESINATE COMPLEX OF S-CLOPIDOGREL AND PRODUCTION METHOD THEREOF | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2007-03-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080226579-A1 | Novel Resinate Complex of S-Clopidogrel and Production Method Thereof | P2RY13, TAS2R40, TAS2R30 | ABCB11 242/4885CYP2C19 273/4885ADRA2A 537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.